CAR T therapy

Allogene Therapeutics Reports Strong ALPHA3 Trial Data

South San Francisco, California | April 13, 2026 Allogene Therapeutics has announced encouraging interim results from its pivotal Phase...

By cGxPwire Editor
April 14, 2026

M&A

Gilead to Acquire Arcellx in $7.8B Cell Therapy Deal

February 24, 2026 — Foster City, CA & Redwood City, CA:Gilead Sciences, Inc. (Nasdaq: GILD) today revealed a definitive...

By cGxPwire Editor
February 24, 2026

Bio-Pharma

Verismo Therapeutics Unveils Promising CAR T Advances for Solid Tumors at SITC 2025

Philadelphia, November 10, 2025 — Verismo Therapeutics, a clinical-stage biotechnology company pioneering KIR-CAR T cell therapies, presented compelling preclinical...

By cGxPwire Editor
November 11, 2025

Bio-Pharma

Verismo Partners with Miltenyi Biotec to Advance KIR-CAR Clinical Programs

Philadelphia, September 25, 2025 – Verismo Therapeutics, a clinical-stage biotechnology company specializing in KIR-CAR T cell therapies, has announced...